Literature DB >> 18590616

Many options for epilepsy: comparisons of first- and second-generation AEDs.

Carl W Bazil.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18590616     DOI: 10.1007/s11910-008-0049-3

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


× No keyword cloud information.
  6 in total

1.  New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine.

Authors:  A J Rowan; R E Ramsay; J F Collins; F Pryor; K D Boardman; B M Uthman; M Spitz; T Frederick; A Towne; G S Carter; W Marks; J Felicetta; M L Tomyanovich
Journal:  Neurology       Date:  2005-06-14       Impact factor: 9.910

2.  Prognosis for total control of complex partial and secondarily generalized tonic clonic seizures. Department of Veterans Affairs Epilepsy Cooperative Studies No. 118 and No. 264 Group.

Authors:  R H Mattson; J A Cramer; J F Collins
Journal:  Neurology       Date:  1996-07       Impact factor: 9.910

Review 3.  A comparison of clinical practice guidelines in the initial pharmacological management of new-onset epilepsy in adults.

Authors:  Nalin Payakachat; Kent H Summers; John P Barbuto
Journal:  J Manag Care Pharm       Date:  2006 Jan-Feb

Review 4.  Epilepsy and common comorbidities: improving the outpatient epilepsy encounter.

Authors:  Frank G Gilliam; Anil Mendiratta; Alison M Pack; Carl W Bazil
Journal:  Epileptic Disord       Date:  2005-09       Impact factor: 1.819

5.  Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group.

Authors:  M J Brodie; A Richens; A W Yuen
Journal:  Lancet       Date:  1995-02-25       Impact factor: 79.321

6.  A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group.

Authors:  R H Mattson; J A Cramer; J F Collins
Journal:  N Engl J Med       Date:  1992-09-10       Impact factor: 91.245

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.